References
- Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496–509.
- Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137:280–284.
- Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002;47:512–518.
- de Jager ME, de Jong EM, van de Kerkhof PC, Evers AW, Seyger MM. An intrapatient comparison of quality of life in psoriasis in childhood and adulthood. J Eur Acad Dermatol Venereol. 2011;25:828–831.
- Christophers E. The immunopathology of psoriasis. Int Arc Allergy Immunol. 1996;110:199–206.
- Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest. 2004;113:1664–1675.
- Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866–873.
- Nickoloff BJ, Qin JZ, Nestle FO. Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol. 2007;33:45–56.
- Rebholz B, Haase I, Eckelt B, Paxian S, Flaig MJ, Ghoreschi K, et al. Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. Immunity. 2007;27:296–307.
- Van de Kerkhof PC, Van Erp PE. The role of epidermal proliferation in the pathogenesis of psoriasis. Skin Pharmacol. 1996;9:343–354.
- Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr, et al. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science. 1989;243:811–814.
- Heidenreich R, Rocken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol. 2009;90:232–248.
- Micali G, Lacarrubba F, Musumeci ML, Massimino D, Nasca MR. Cutaneous vascular patterns in psoriasis. Int J Dermatol. 2010;49:249–256.
- Telner P, Fekete Z. The capillary responses in psoriatic skin. J Invest Dermatol. 1961;36:225–230.
- Kulka JP. Microcirculatory impairment as a factor in inflammatory tissue damage. Ann N Y Acad Sci. 1964;116:1018–1044.
- Hull SM, Goodfield M, Wood EJ, Cunliffe WJ. Active and inactive edges of psoriatic plaques: identification by tracing and investigation by laser – Doppler flowmetry and immunocytochemical techniques. J Invest Dermatol. 1989;92:782–785.
- Goodfield M, Hull SM, Holland D, Roberts G, Wood E, Reid S, et al. Investigations of the 'active' edge of plaque psoriasis: vascular proliferation precedes changes in epidermal keratin. Br J Dermatol. 1994;131:808–813.
- Staton CA, Reed MW, Brown NJ. A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol. 2009;90:195–221.
- Staton CA, Stribbling SM, Tazzyman S, Hughes R, Brown NJ, Lewis CE. Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol. 2004;85:233–248.
- Draijer M, Hondebrink E, van Leeuwen T, Steenbergen W. Twente optical perfusion camera: system overview and performance for video rate laser Doppler perfusion imaging. Opt Express. 2009;17:3211–3225.
- Gerritsen MJ, van Erp PE, van Vlijmen-Willems IM, Lenders LT, van de Kerkhof PC. Repeated tape stripping of normal skin: a histological assessment and comparison with events seen in psoriasis. Arch Dermatol Res. 1994;286:455–461.
- Wiley HE 3rd, Weinstein GD. Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo. J Invest Dermatol. 1979;73:545–547.
- Williams MG, Hunter R. Studies on epidermal regeneration by means of the strip method. J Invest Dermatol. 1957;29:407–413.
- Hern S, Stanton AW, Mellor R, Levick JR, Mortimer PS. Control of cutaneous blood vessels in psoriatic plaques. J Invest Dermatol. 1999;113:127–132.